| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |